Apoptosis, or programmed cell death, plays a crucial role in maintaining cell homeostasis. Abnormal regulation of apoptosis has been linked to various diseases, including cancer. In ovarian cancer, one of the most lethal gynecological malignancies, dysregulation of apoptosis-related non-coding RNAs is heavily involved in the progression and poor prognosis of the disease.
Non-coding RNAs (ncRNAs) are RNA molecules that do not encode proteins, but they play an essential role in gene regulation. They can be broadly classified into two groups: small ncRNAs (such as microRNAs) and long ncRNAs (lncRNAs). Both types have been implicated in the regulation of apoptosis pathway and, thus, in ovarian cancer development.
MicroRNAs are a class of small ncRNAs that regulate gene expression post-transcriptionally. Some microRNAs function as tumor suppressors, while others act as oncogenes. For instance, miR-125b, miR-200c, and miR-199a are associated with chemotherapy resistance in ovarian cancer by targeting anti-apoptotic genes or apoptosis regulators.
On the other hand, lncRNAs are a type of ncRNA measuring over 200 nucleotides in length. They are involved in many biological processes, including modulation of apoptosis. Studies show that some lncRNAs (e.g., HOTAIR, MALAT1, and MEG3) possess significant roles in ovarian cancer progression by regulating apoptotic pathways.
Therefore, understanding the mechanisms of apoptosis-related ncRNAs in ovarian cancer will contribute to identifying potential therapeutic targets and improving treatment strategies. However, the complex nature of ncRNA interaction networks presents substantial challenges in achieving this goal. Future research is needed to unravel the comprehensive functions and interactions of ncRNAs in the regulation of apoptosis in ovarian cancer. |
求助已关闭
30